Bartlett Discusses CURES 2.0 and Drug Development at BIO CEO & Investor Conference

Join Chamber Hill Strategies’ Melissa Bartlett for a panel discussion on CURES 2.0 Legislation and Patient-Focused Drug Development Opportunities as part of the BIO CEO & Investor Conference next week.

Registration is now open: https://bit.ly/3k2bwZJ